Cargando…

Emerging Proteins in CRPC: Functional Roles and Clinical Implications

Prostate cancer (PCa) is the most common cancer in men in the western world, but the lack of specific and sensitive markers often leads to overtreatment of prostate cancer which eventually develops into castration-resistant prostate cancer (CRPC). Novel protein markers for diagnosis and management o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kong, Piaoping, Zhang, Lingyu, Zhang, Zhengliang, Feng, Kangle, Sang, Yiwen, Duan, Xiuzhi, Liu, Chunhua, Sun, Tao, Tao, Zhihua, Liu, Weiwei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9226405/ https://www.ncbi.nlm.nih.gov/pubmed/35756667 http://dx.doi.org/10.3389/fonc.2022.873876

Ejemplares similares

SGK1 in Human Cancer: Emerging Roles and Mechanisms
por: Sang, Yiwen, et al.
Publicado: (2021)

New insights into lipid metabolism and prostate cancer (Review)
por: Zhang, Zhengliang, et al.
Publicado: (2023)

The MYH9 Cytoskeletal Protein Is a Novel Corepressor of Androgen Receptors
por: Liu, Chunhua, et al.
Publicado: (2021)

Exosomal miR‐222‐3p contributes to castration‐resistant prostate cancer by activating mTOR signaling
por: Wang, Weixi, et al.
Publicado: (2023)

Emerging proteins involved in castration-resistant prostate cancer via the AR-dependent and AR-independent pathways (Review)
por: Feng, Kangle, et al.
Publicado: (2023)

Emerging roles and mechanisms of microRNA-222-3p in human cancer (Review)
por: Wang, Danhua, et al.
Publicado: (2021)

Saracatinib synergizes with enzalutamide to downregulate AR activity in CRPC
por: White, Ralph E., et al.
Publicado: (2023)

Adefovir dipivoxil inhibits APL progression through degradation of the oncoprotein PML-RARA
por: Gong, Xubo, et al.
Publicado: (2022)

A Multivariate Diagnostic Model Based on Urinary EpCAM-CD9-Positive Extracellular Vesicles for Prostate Cancer Diagnosis
por: Dai, Yibei, et al.
Publicado: (2021)

Integrated profiling identifies SLC5A6 and MFAP2 as novel diagnostic and prognostic biomarkers in gastric cancer patients
por: Sun, Tao, et al.
Publicado: (2019)

Circulating tumor cells in prostate cancer: Precision diagnosis and therapy
por: Liu, Weiwei, et al.
Publicado: (2017)

Androgen-independent LNCaP cells are a subline of LNCaP cells with a more aggressive phenotype and androgen suppresses their growth by inducing cell cycle arrest at the G1 phase
por: Yu, Pan, et al.
Publicado: (2017)

Central Nervous System-related Conditions and Associated Healthcare Resource Use Among Japanese nmCRPC Patients Based on Retrospective Claims Data
por: Ledesma, Dianne A., et al.
Publicado: (2023)

Rapid and sensitive detection of L‐FABP for prediction and diagnosis of acute kidney injury in critically ill patients by chemiluminescent immunoassay
por: Sun, Tao, et al.
Publicado: (2021)

The prognosis value of EphA3 and the androgen receptor in prostate cancer treated with radical prostatectomy
por: Duan, Xiuzhi, et al.
Publicado: (2019)

Current and Emerging Therapies for Metastatic Castration-Resistant Prostate Cancer (mCRPC)
por: Henríquez, Iván, et al.
Publicado: (2021)

What Plasma Can Tell Us When Tissue Cannot: A Case Report of Genomic Testing in mCRPC and Clinical Response to Treatment With the PARP Inhibitor Rucaparib
por: Petrylak, Daniel P., et al.
Publicado: (2022)

Targeted Alpha Therapy in mCRPC (Metastatic Castration-Resistant Prostate Cancer) Patients: Predictive Dosimetry and Toxicity Modeling of (225)Ac-PSMA (Prostate-Specific Membrane Antigen)
por: Belli, Maria Luisa, et al.
Publicado: (2020)

Roles of Plasmacytoid Dendritic Cells in Gastric Cancer
por: Yang, Jinpu, et al.
Publicado: (2022)

RON and c-Met facilitate metastasis through the ERK signaling pathway in prostate cancer cells
por: Yin, Binbin, et al.
Publicado: (2017)

RON and c-Met facilitate metastasis through the ERK signaling pathway in prostate cancer cells
por: Yin, Binbin, et al.
Publicado: (2022)

Systematically understanding the immunity leading to CRPC progression
por: Ji, Zhiwei, et al.
Publicado: (2019)

The Development of Single-Cell Metabolism and Its Role in Studying Cancer Emergent Properties
por: Wei, Dingju, et al.
Publicado: (2022)

SGK1 inhibition induces autophagy-dependent apoptosis via the mTOR-Foxo3a pathway
por: Liu, Weiwei, et al.
Publicado: (2017)

Therapeutic potential of ReACp53 targeting mutant p53 protein in CRPC
por: Zhang, Yaqun, et al.
Publicado: (2019)

Emerging Role of Circular RNAs in Cancer
por: Liu, Jing, et al.
Publicado: (2020)

How to better select SARS‐CoV‐2 preservation solution of virus nucleic acid testing
por: Duan, Xiuzhi, et al.
Publicado: (2023)

Mechanisms of resistance in castration-resistant prostate cancer (CRPC)
por: Chandrasekar, Thenappan, et al.
Publicado: (2015)

Recent Advances on the Role of ATGL in Cancer
por: Zhang, Renshuai, et al.
Publicado: (2022)

Pan-cancer analysis of kinesin family members with potential implications in prognosis and immunological role in human cancer
por: Zhong, Ming, et al.
Publicado: (2023)

Comprehensive analysis of the progression mechanisms of CRPC and its inhibitor discovery based on machine learning algorithms
por: Wang, Zhen, et al.
Publicado: (2023)

Role of Ubiquitination in PTEN Cellular Homeostasis and Its Implications in GB Drug Resistance
por: Xia, Qin, et al.
Publicado: (2020)

The emerging double-edged sword role of Sirtuins in the gastric inflammation-carcinoma sequence revealed by bulk and single-cell transcriptomes
por: Wang, Mengyang, et al.
Publicado: (2022)

SGK1 inhibition-induced autophagy impairs prostate cancer metastasis by reversing EMT
por: Liu, Weiwei, et al.
Publicado: (2018)

The role of microbiota in the development and treatment of gastric cancer
por: Wang, Yiwen, et al.
Publicado: (2023)

Combined Use of Fecal Biomarkers in Inflammatory Bowel Diseases: Oncostatin M and Calprotectin
por: Cao, Ying, et al.
Publicado: (2021)

The emerging role of miR-20b in human cancer and other disorders: Pathophysiology and therapeutic implications
por: Khalilian, Sheyda, et al.
Publicado: (2022)

Type I Interferon Promotes Antitumor T Cell Response in CRPC by Regulating MDSC
por: Fan, Lilv, et al.
Publicado: (2021)

A key driver to promote HCC: Cellular crosstalk in tumor microenvironment
por: Liu, Pengyue, et al.
Publicado: (2023)

Amplification of MUC1 in prostate cancer metastasis and CRPC development
por: Wong, Nicholas, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_l6j9mt7qinhcm3t0hkavqen4g9